

N. Anthony Coles, M.D. and Robyn Coles | First Republic Bank



















































×
Secure Sign In



                        Banking Online
                        



                        Banking Online
                        



                        Corporate Online
                        



                        Corporate Online
                        



                        Brokerage Online
                        



                        Trust Online
                        



                        Foreign Exchange Online
                        



                        Eagle Invest
                        



                        Banking Online Full Site
                        



                        Corporate Online Full Site
                        




Search

 


Search
 Cancel










Also Find Us on:





























x
Notice: This website is not optimized for your current browser.

Please take action to ensure continued access to FirstRepublic.com. We will be discontinuing service to older web browsers with outdated security settings. Please update to the latest version of Google Chrome, Internet Explorer, Safari or Firefox. For assistance, please call (888) 372-4891.
















Whatever we need, this is a bank that makes things happen.
Whatever we need, this is a bank that makes things happen.

N. Anthony Coles, M.D. and Robyn Coles
|

                                        Northern California, San Francisco
                                    
Clients of First Republic Bank Since ‘10









Dr. N. Anthony Coles, a cardiovascular specialist and accomplished healthcare executive, relocated to San Francisco with his wife Robyn in 2007. They were looking for a bank with an excellent level of service to help them finance their new home. Friends recommended First Republic. They soon discovered that home lending is the bedrock of First Republic and they were able to choose from a variety of products to meet their needs.  

                            Pictured Above
                            Robyn Coles, Community Volunteer 
N. Anthony Coles, M.D.
                        





Related Testimonials










Duane and Barbara McDougall













Garret Tom and Family













Ed and Peggy Kavounas








See All













Share



Email


Twitter


Facebook


LinkedIn








Recent Articles



Five Signs You’re Ready to Buy Your First Home




Pass on Your Assets Wisely: How to Choose the Right Beneficiaries




Passing Along an Inheritance? Five Tips for Preparing Your Heirs









 All Testimonials











Get Started Today
Our Relationship Managers are ready to tailor financial solutions to suit your individual needs.


Give us a call

Give us a call

Our Relationship Managers are ready to tailor financial solutions to suit your individual needs.


(855) 886-4824







Have us contact you

Have us contact you

If you'd prefer to have us reach out to you, complete the online form and we will be in touch.


Continue to form






Find an office near you

Find an office near you

We welcome you to visit our locations. Use our locator to find one of our offices near you.


Find an office































N. Anthony Coles M.D., M.P.H.: Executive Profile & Biography - Bloomberg









































  





















































































July 24, 2017 5:06 AM ET
Life Sciences Tools and Services

Company Overview of Yumanity Therapeutics Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
N. Anthony Coles M.D., M.P.H.Chairman and Chief Executive Officer, Yumanity Therapeutics Inc.AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 12 different industries.See Board Relationships57--
Background

		Dr. N. Anthony Coles, also known as Tony, M.D., M.P.H., serves as the Chairman and Chief Executive Officer of TRATE Enterprises, LLC. Dr. Coles serves as the Chief Executive Officer of Yumanity Therapeutics Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles served as Senior Vice President of Commercial Operations-Pharmaceutical Products of Vertex Pharmaceuticals Incorporated from March 2002 to November 1, 2005 and also served as its Head of Global Corporate and ... Business Development. Dr. Coles joined Vertex Pharmaceuticals Incorporated in March, 2002. Prior to joining Onyx in 2008, Dr. Coles served as the Chief Executive Officer of NPS Pharmaceuticals, Inc. from May 11, 2006 to March 17, 2008 and also its President from November 2, 2005 to March 17, 2008 and Chief Operating Officer from November 2, 2005 to May 11, 2006. Dr. Coles is an accomplished physician and executive leader. Dr. Coles served as the Chief Executive Officer at Onyx Pharmaceuticals, Inc. since March 31, 2008 and also served as its President since March 31, 2008 and again since 2012. Beginning in 1996, he held a number of executive positions at Bristol-Myers Squibb Company, including Senior Vice President of Strategy & Policy, Senior Vice President of Marketing & Medical Affairs, Neuroscience/Infectious Diseases/Dermatology, Vice President of West Area Sales-Cardiovascular and Metabolic Business Unit for U.S. Primary Care and Vice President of Cardiovascular Global Marketing of BMS. From 1996 to 2000, he held a variety of senior positions in cardiovascular franchise management and sales at Bristol-Myers Squibb. From 1992 to 1996, Dr. Coles also held a number of positions of increasing responsibility at Merck & Co., Inc., including Vice President of the Hypertension and Heart Failure Business Group. He began his business career at Merck & Co. in 1992. He has been the Chairman of the Board of CRISPR Therapeutics AG since March 17, 2016 and as its Independent Director since October 2015. He serves as the Chairman of Yumanity Therapeutics Inc. He served as the Chairman of the Board and Director at Onyx Pharmaceuticals, Inc since December 17, 2012 and March 31, 2008 respectively. He serves as Vice Chair of the Board of Trustees for Johns Hopkins University. He has been a Director of McKesson Corporation since April 29, 2014 and Regeneron Pharmaceuticals, Inc. since January 27, 2017. He has been an Independent Director of Seragon Pharmaceuticals Inc. since March 24, 2014. He serves as a Director of New York City Investment Fund Manager, Inc. He serves as a Director of FoldRx Pharmaceuticals Inc. He has been a Trustee of Johns Hopkins Medicine, Inc. since July 1, 2010. Dr. Coles serves as a Member of the board of the U.S. Olympic and Paralympic Foundation. Dr. Coles is also a Member of The Board of the Biotechnology Industry Organization (BIO). He serves as Trustee for Johns Hopkins University and Boston Medical Center. He is a Member of The Board of Trustees at Johns Hopkins Medicine. He served as a Director of NPS Pharmaceuticals Inc. from November 02, 2005 to March 17, 2008. He served as Director of Laboratory Corporation of America Holdings since January 1, 2011. He served as an Independent Director at Campus Crest Communities, Inc. from October 2010 to April 22, 2013. He served as a Trustee for The Johns Hopkins Hospital since July 2010. In March 2015, Dr. Coles was named to the NIH working group tasked with charting the course for President Obama’s Precision Medicine Initiative. He was a Research Fellow at Harvard Medical School. He completed his Cardiology and Internal Medicine Training at Massachusetts General Hospital. Dr. Coles holds a Bachelor of Science degree from Johns Hopkins University, a Master's degree in Public Health from Harvard University and a MD degree from Duke University.Read Full Background




Corporate Headquarters
790 Memorial DriveCambridge, Massachusetts 02139United StatesPhone: 617-409-5300Fax: --
Board Members Memberships
DirectorNew York City Investment Fund Manager, Inc.DirectorFoldRx Pharmaceuticals, Inc.TrusteeJohns Hopkins Medicine, Inc.Chairman and Chief Executive OfficerYumanity Therapeutics Inc.2008-PresentChairmanOnyx Pharmaceuticals, Inc.2014-PresentDirectorMcKesson Corporation2014-PresentIndependent DirectorSeragon Pharmaceuticals Inc.2015-PresentChairman of the BoardCRISPR Therapeutics AG2017-PresentDirectorRegeneron Pharmaceuticals, Inc.
Education
Master's Degree Harvard UniversityMD Duke UniversityBS Johns Hopkins University
Other Affiliations
Laboratory Corporation of America HoldingsOnyx Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Vertex Pharmaceuticals IncorporatedNew York City Investment Fund Manager, Inc.Harvard UniversityMcKesson CorporationNPS Pharmaceuticals, Inc.Duke UniversityJohns Hopkins UniversityThe Johns Hopkins HospitalFoldRx Pharmaceuticals, Inc.Johns Hopkins Medicine, Inc.Campus Crest Communities, Inc.Seragon Pharmaceuticals Inc.CRISPR Therapeutics AG


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Yumanity Therapeutics Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close



































N. Anthony Coles, M.D. (Photo: Business Wire) - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































N. Anthony Coles, M.D. (Photo: Business Wire)






Business Wire




Mar 5, 2014 4:15 PM EST













 




























































  As a next step in a series of corporate governance modifications, McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29, 2014. In connection with Dr. Coles’ election, the size of the Board of Directors was increased from nine to ten members, nine of whom are independent.   N. Anthony Coles, M.D. (Photo: Business Wire)   “With over 20 years of experience in the biopharmaceuticals and pharmaceutical industries, including several public company leadership positions, Tony will provide unique perspectives that will further diversify the expertise of our Board,” said John H. Hammergren, chairman and chief executive officer, McKesson Corporation. “We are committed to maintaining the best possible leadership team to continue guiding our strong financial performance. The addition of Tony to our Board represents a continuation of initiatives already under way to address shareholder feedback and maintain industry-leading governance practices.”  The Board has appointed Dr. Coles as a member of its Compensation Committee and its Finance Committee. Dr. Coles’ term as a director will expire at the Company’s 2014 Annual Meeting of Stockholders unless he is renominated as a director, and elected by stockholders at the annual meeting in accordance with McKesson’s majority voting standard.  N. Anthony Coles, M.D.  Dr. Coles, 53, was President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, from 2012 until 2013, having served as its President and Chief Executive Officer, and a member of its board of directors, from 2008 until 2012. From 2005 to 2008, Dr. Coles served as an executive and a director of NPS Pharmaceuticals, Inc., a public biopharmaceutical company (“NPS”). Dr. Coles began his tenure at NPS as President and Chief Operating Officer and ended his tenure there as President and Chief Executive Officer. Prior to 2005, Dr. Coles served in various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated.  



 








 










































If you liked this article you might like













Nvidia Battles for AI Supremacy; Apple's Creative Direction Called Into Question -- ICYMI Wednesday
Here's what you need to know now.



Michael Brown

Jul 19, 2017 7:37 PM EDT
























UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round
Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.



Scott Rutt

Jul 19, 2017 6:30 AM EDT
























Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)
Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.



Scott Rutt

Jul 19, 2017 6:20 AM EDT
























Bristol Myers Vies to Be King of Immune-Boosting Cancer Drugs with New Trial Update
The trial's success props open doors for exploring new uses for Opdivo's treatment in immunotherapy.



Melissa Angell

Jul 9, 2017 8:38 PM EDT








































 











Trending


Trump Just Resurrected the Ugly Practice Known as Civil Forfeiture for No Reason


Walmart in Focus Amid 'Horrific' Human Trafficking Incident in Texas That Causes Nine Deaths


FTC Seen as Set to Block Rite Aid Deal


Billionaire Mark Cuban: The Rise of Technology Will Cause a Lot of Unemployment


As Snap Continues to Stumble, Should It Consider Selling Itself?











Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 












Request unsuccessful. Incapsula incident ID: 574000390115129377-159776777768403572




	N. Anthony Coles, M.D. | McKesson





   
























McKesson


CareersInvestorsContact UsCustomer Login




Search








Solutions 






ProvidersAll Solutions for ProvidersDistributionPharmaceutical Ordering and PackagingMedical Supplies and EquipmentTechnology and ServicesGrowth and ExpansionOperational EfficiencyPatient and Clinical CareRegulatory and Risk ManagementReimbursement and Revenue Cycle ManagementPharmaciesAll Solutions for PharmaciesDistributionPharmaceutical DistributionSupplies, Equipment and MerchandiseExpertise and TechnologyFinancial PerformanceGrowth and ExpansionMedication Adherence and Clinical PerformanceOperational EfficiencyHealth PlansAll Solutions for Health PlansConsumer EngagementHealth Care ReimbursementMedical Cost and Care QualityOperational EfficiencyPopulation HealthProvider EngagementManufacturersAll Solutions for ManufacturersPharmaceutical DistributionThird Party LogisticsPharmaceutical PackagingGroup Purchasing Organization ServicesClinical Trial ServicesHealth Care InformaticsCommercial Services



All Solutions





Providers All Solutions for ProvidersDistributionPharmaceutical Ordering and PackagingMedical Supplies and EquipmentTechnology and ServicesGrowth and ExpansionOperational EfficiencyPatient and Clinical CareRegulatory and Risk ManagementReimbursement and Revenue Cycle Management
Pharmacies All Solutions for PharmaciesDistributionPharmaceutical DistributionSupplies, Equipment and MerchandiseExpertise and TechnologyFinancial PerformanceGrowth and ExpansionMedication Adherence and Clinical PerformanceOperational Efficiency
Health Plans All Solutions for Health PlansConsumer EngagementHealth Care ReimbursementMedical Cost and Care QualityOperational EfficiencyPopulation HealthProvider Engagement
Manufacturers All Solutions for ManufacturersPharmaceutical DistributionThird Party LogisticsPharmaceutical PackagingGroup Purchasing Organization ServicesClinical Trial ServicesHealth Care InformaticsCommercial Services
All Solutions
Blog
About Us



More >















HomeInvestorsCorporate GovernanceBoard of Directors BiosN. Anthony Coles, M.D.












N. Anthony Coles, M.D.
Chairman and Chief Executive Officer, Yumanity Therapeutics, LLC; Formerly Chairman and Chief Executive Officer, Onyx Pharmaceuticals, Inc.






Dr. Coles was named Chairman and Chief Executive Officer of Yumanity Therapeutics, LLC, a company focused on transforming drug discovery for neurodegenerative diseases, in October 2014. Prior to this, from October 2013, Dr. Coles served as Chairman and CEO of TRATE Enterprises LLC, a privately-held company. Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals, Inc., a biopharmaceutical company (“Onyx”), from 2012 until 2013, having served as its President, Chief Executive Officer and a member of its board of directors from 2008 until 2012. Prior to joining Onyx in 2008, he was President, Chief Executive Officer and a member of the board of directors of NPS Pharmaceuticals, Inc., a public biopharmaceutical company (“NPS”). Before joining NPS in 2005, he served in various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated. In addition to having previously served as a director of Onyx and NPS, he was formerly a director of Laboratory Corporation of America Holdings and Campus Crest Communities, Inc. Dr. Coles has been a director of the Company since April 2014. He is a member of the Compensation Committee and the Finance Committee.
 























































top

































Insider Trading - Coles N Anthony - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Coles N Anthony





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-24Option Award
2016-10-266:28 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Coles N AnthonyDirector
35,000
$14
70,000(Indirect)
View


2016-10-24Option Award
2016-10-266:28 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Coles N AnthonyDirector
35,000
$14
70,000(Indirect)
View


2016-10-18Option Award
2016-10-205:16 pm
N/A2026-10-18
Crispr Therapeutics Ag
CRSP
Coles N AnthonyDirector
15,000
$14
15,000(Direct)
View


2016-07-27Option Award
2016-07-286:04 pm
N/AN/A
Mckesson Corp
MCK
Coles N AnthonyDirector
915
$0
915(Direct)
View


2015-07-29Option Award
2015-07-315:01 pm
N/AN/A
Mckesson Corp
MCK
Coles N AnthonyDirector
794
$0
794(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Mon, 24 Jul 2017 04:06:35 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  



















 


Anthony N. Coles, Board Dir., FoldRx Pharmaceuticals Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Anthony Coles 





 


Anthony Coles

 

Board Dir. - FoldRx Pharmaceuticals Inc.

 


Anthony Coles Email :
Please login 

 

Company Name : 
FoldRx Pharmaceuticals Inc. 

 

Company Website : 
www.foldrx.com 

 

Company Address : 
100 Acorn Pk. Dr.5th Fl., Cambridge, MA,United States, 


 


Anthony Coles Profile :
Board Dir. - FoldRx Pharmaceuticals Inc. 

 


Anthony Coles Biography :


N. Anthony Coles joined NPS Pharmaceuticals in November 2005 as President, Chief Operating Officer, and a member of the NPS Board of Directors. In May 2006 he was appointed to Chief Executive Officer. Dr. Coles joined NPS from Vertex Pharmaceuticals where he was Senior Vice President, Commercial Operations and Pharmaceutical Products. His experience includes a variety of positions with Bristol-Myers Squibb, beginning in 1996, including Senior Vice president of Strategy and Policy, Senior Vice President, Marketing and Medical Affairs for the Neuroscience, Infectious Disease and Dermatology Division, Vice President, West Area Sales-Cardiovascular and Metabolic Business Unit for U.S. Primary Care, and Vice President, Cardiovascular Global Marketing. Prior to joining BMS, Dr. Coles was Vice President of the Hypertension and Heart Failure business Group at Merck. Dr. Coles holds an M.D. from Duke University, a Masters Degree in Public Health from Harvard University and a B.S. from Johns Hopkins University. 

 


Anthony Coles Colleagues :





Name 
Title 
Email 


Richard Labaudiniere 
Dir., Pres., CEO 
Please login 


Christoph Adams 
Chief Business Officer 
Please login 


Christine Bulawa 
Sr. Dir., Research 
Please login 


Donna Grogan 
Chief Medical Officer 
Please login 


Jeff Packman 
VP, Drug Development Operations 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

� 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.



 









N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals, Inc. - YouTube 


 
  

















































 
 

 
Skip navigation
  
 

 
Sign inSearch

 





Loading...
    






 


Close

 


 

 Yeah, keep it
Undo
Close
 




              This video is unavailable.

    







Watch QueueQueueWatch QueueQueue 
Remove allDisconnect







The next video is startingstop 


Loading...
    

 



 

Watch Queue
    
Queue

__count__/__total__
    









 









































 


 

Find out whyClose






    N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals, Inc.
  



 










Biotechnology Innovation Organization













Loading...
    







        Unsubscribe from Biotechnology Innovation Organization?
      


Cancel
Unsubscribe










        Working...
    










SubscribeSubscribedUnsubscribe3.1K 











Loading...
    









Loading...
    













        Working...
    












 
Add to

Want to watch this again later?

      Sign in to add this video to a playlist.
    
Sign in


Share

 More
 


Report


Need to report the video?

      Sign in to report inappropriate content.
    
Sign in





Transcript




Statistics



Add translations

700 views







1

Like this video?

      Sign in to make your opinion count.
    
Sign in



2


0

Don't like this video?

      Sign in to make your opinion count.
    
Sign in



1











Loading...
    











Loading...
    





Transcript
    





The interactive transcript could not be loaded.
      








Loading...
    








Loading...
    





Rating is available when the video has been rented.




      This feature is not available right now. Please try again later.
    



Published on Feb 26, 2013N. Anthony Coles, MDChairman & CEO, Onyx PharmaceuticalsDr. Coles joined Onyx in March 2008 as President and Chief Executive Officer. In 2012, Dr. Coles was appointed as Chairman of the board of directors. Prior to joining Onyx, he was President, Chief Executive Officer, and a member of the board of directors of NPS Pharmaceuticals, Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles was Senior Vice President of Commercial Operations at Vertex Pharmaceuticals Incorporated, which he joined in 2002. Beginning in 1996, he held a number of executive positions while at Bristol-Myers Squibb Company, including Senior Vice President of Strategy and Policy; Senior Vice President of Marketing and Medical Affairs, Neuroscience/Infectious Diseases/Dermatology; Vice President, Western Area Sales Cardiovascular and Metabolic Business Unit for U.S. Primary Care; and Vice President, Cardiovascular Global Marketing. From 1992 until 1996, Dr. Coles also held a number of positions of increasing responsibility at Merck & Co., Inc., including Vice President of the Hypertension and Heart Failure Business GroupDr. Coles completed his cardiology and internal medicine training at Massachusetts General Hospital and was a research fellow at Harvard Medical School. He earned an M.D. degree from Duke University, a master's degree in public health from Harvard University, and an undergraduate degree from Johns Hopkins University. Dr. Coles currently serves as a trustee and member of the Executive Committee for the Johns Hopkins University Board of Trustees, as well as a member of the board of trustees for Johns Hopkins Medicine. Dr. Coles is also a member of the board of directors for Laboratory Corporation of America (LabCorp), as well as Campus Crest Communities, Inc., both NYSE traded companies. He is also a member of the board of the Biotechnology Industry Organization (BIO). 



      Category
    

Science & Technology




      License
    

Standard YouTube License




 Show more
Show less






Loading...
    















Autoplay


When autoplay is enabled, a suggested video will automatically play next. 

 


        Up next
      






    N. Anthony Coles, M.D., Onyx Pharmaceuticals, speaking  at the 2012 MMRF Fall Gala
  

     - Duration: 7:42.
  
Multiple Myeloma Research Foundation - MMRF
910 views



7:42














    From the 2012 Aspen Ideas Festival: CEO Series: Pharma Leader Anthony Coles, Onyx
  

     - Duration: 3:54.
  
The Aspen Institute
615 views



3:54





    Fireside Chat with N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals
  

     - Duration: 38:48.
  
Biotechnology Innovation Organization
1,916 views



38:48



 Ask Jay
S1 • E45

    Ask Jay - Important Distinctions:  Chairman vs CEO
  

     - Duration: 7:16.
  
Jay
18,193 views



7:16





    Chairman vs CEO | London Business School
  

     - Duration: 1:31.
  
London Business School
1,512 views



1:31





    On Kalydeco 5 months
  

     - Duration: 3:45.
  
M Rich
1,906 views



3:45





    Cramer Interviews Medicis Pharmaceutical CEO
  

     - Duration: 4:57.
  
TheStreet
260 views



4:57





    On the Affordable Care Act
  

     - Duration: 4:23.
  
The Aspen Institute
169 views



4:23





    Which Foods increase your risk for Alzheimers? with Dr. Daniel Amen, M.D.
  

     - Duration: 4:56.
  
David Wolfe® & Longevity Now®
41,936 views



4:56





    The difference between Chairman of the Board, CEO and...
  

     - Duration: 0:43.
  
WatchMojo.com
3,605 views



0:43





    Robert J. Hugin, Chairman & CEO of Celgene Corporation
  

     - Duration: 1:09:53.
  
DardenMBA
3,748 views



1:09:53





    Spotlight - Onyx Pharmaceuticals - Bloomberg
  

     - Duration: 4:41.
  
Bloomberg
307 views



4:41





    Kevin Sharer, Chairman of the Board, CEO & President, Amgen
  

     - Duration: 55:16.
  
DardenMBA
3,415 views



55:16





    MILE Webrary | Difference Between A CEO And Chairman by Francois E  Aubert
  

     - Duration: 1:53.
  
Mile Madinah
134 views



1:53





    Oncology: A Case Study in Innovation & Access
  

     - Duration: 50:35.
  
California Life Sciences Association (CLSA)
1,115 views



50:35





    Ancora Indonesia CEO Dharma Djojonegoro on the pharmaceutical industry
  

     - Duration: 6:48.
  
INSEAD
767 views



6:48





    Tony Coles, Yumanity Therapeutics ALS Ice Bucket Challenge
  

     - Duration: 0:49.
  
Yumanity Therapeutics
216 views



0:49





    MD turned pharma CEO
  

     - Duration: 5:26.
  
Washington Post
3,581 views



5:26





    Coles Says Onyx Aims to `Accelerate' Drug Development: Video
  

     - Duration: 5:53.
  
Bloomberg
182 views



5:53





    Tendonitis: an animation
  

     - Duration: 3:18.
  
NHS Choices
323,351 views



3:18




Loading more suggestions...
    

Show more









  

 
Language:
  
  English



 
Content location:
  
  United States



 
Restricted Mode:
  
Off



History Help





Loading...
    






Loading...
    






Loading...
    


 About
Press
Copyright
Creators
Advertise
Developers
+YouTube
 Terms
Privacy

Policy & Safety
  
Send feedback

Test new features













Loading...
    














        Working...
    









 
Sign in to add this to Watch Later

    
 

Add to
    





        Loading playlists...
    


 


 




Coles N Anthony Cummings - Princeton, NJ | Intelius



























Sign In



We found Coles N Anthony Cummings in Princeton, NJ


Coles N Anthony Cummings

                                                                        Intelius found that Coles N Anthony Cummings  from Princeton, NJ.  We have connected them to
                1 address,
                0 phones,
                and 1 relative or associate.
         






Get Report Now

Coles Has Lived In

Princeton, NJ

Coles's Relatives

Robyn Coles







Coles N Anthony Cummings



Get Report Now










Want to know more about Coles? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Coles, or use our people search engine to find others.
Get Background Check on Coles N Anthony Cummings
Get a Criminal Check on Coles N Anthony Cummings
Get a Public Record Report on Coles N Anthony Cummings
Get a People Search Report on Coles N Anthony Cummings


Coles N Anthony Cummings's Contact Information
Known Cities Lived In
Find out where Coles N Anthony Cummings has lived as well as Coles N Anthony Cummings's phone numbers and email addresses.




Coles N Anthony Cummings Has Lived in 1 States
New Jersey Address for Coles N Anthony Cummings


151 H******* T** 

Princeton, NJ


Has Lived In

Princeton, NJ


Get Full Address Report










Phone Numbers Associated with Coles N Anthony Cummings



Get Full Phone Report



Email Addresses Associated with Coles N Anthony Cummings



Get Email Report




Coles N Anthony Cummings's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Coles N Anthony Cummings


Coles N Anthony Cummings's known Social Networks And Potential Email Matches

Find all of Coles N Anthony Cummings's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Coles Cummings
Username Matches

                  ColesCummings
                  CummingsColes
                  Coles.Cummings
                  Cummings.Coles
                  Coles_Cummings
                  Cummings_Coles
                  Coles-Cummings
                  Cummings-Coles
                  CCummings
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
C Cummings







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.











